Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Harrington Heart and Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, OH.
Division of Vascular Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN.
J Vasc Surg. 2023 Apr;77(4):1192-1198. doi: 10.1016/j.jvs.2022.12.013. Epub 2022 Dec 20.
Patients can be considered at high risk for carotid endarterectomy (CEA) because of either anatomic or physiologic factors and will often undergo transcarotid artery revascularization (TCAR). Patients with physiologic criteria will be considered to have a higher overall surgical risk because of more significant comorbidities. Our aim was to study the incidence of stroke, myocardial infarction (MI), death, and combined end points for patients who had undergone TCAR stratified by the risk factors (anatomic vs physiologic).
An analysis of prospectively collected data from the ROADSTER (pivotal; safety and efficacy study for reverse flow used during carotid artery stenting procedure), ROADSTER 2 (Food and Drug Administration indicated postmarket trial; postapproval study of transcarotid artery revascularization in patients with significant carotid artery disease), and ROADSTER extended access TCAR trials was performed. All 851 patients were considered to be at high risk for CEA and were included and stratified using high-risk anatomic criteria (ie, contralateral occlusion, tandem stenosis, high cervical artery stenosis, restenosis after previous endarterectomy, bilateral carotid stenting, hostile neck anatomy with previous neck irradiation, neck dissection, cervical spine immobility) or high-risk physiologic criteria (ie, age >75 years, multivessel coronary artery disease, history of angina, congestive heart failure New York Heart Association class III/IV, left ventricular ejection fraction <30%, recent MI, severe chronic obstructive pulmonary disease, permanent contralateral cranial nerve injury, chronic renal insufficiency). For trial inclusion, asymptomatic patients were required to have had ≥80% carotid stenosis and symptomatic patients to have had ≥50% stenosis. The primary outcome measures were stroke, death, and MI at 30 days. The data were statistically analyzed using the χ test, as appropriate.
A total of 851 high surgical risk patients were categorized into two groups: those with anatomic-only risk factors (n = 372) or at least one physiologic risk factor present (n = 479). Of the 851 patients, 74.5% of those in the anatomic subset were asymptomatic, and 76.6% in the physiologic subset were asymptomatic. General anesthesia was used similarly in both groups (67.7% anatomic vs 68.1% physiologic). MI had occurred in eight patients in the physiologic group (1.7%), all of whom had been asymptomatic and in none of the anatomic patients (P = .01). The combined stroke, death, and MI rate was 2.1% in the anatomic cohort and 4.2% in the physiologic cohort (P = .10). Stratification of each group into asymptomatic and symptomatic patients did not yield any further differences.
The patients who had undergone TCAR in the present prospective, neurologically adjudicated trial because of high-risk physiologic factors had had a higher rate of MI compared with the patients who had qualified for TCAR using anatomic criteria only. These patients had experienced comparable rates of combined stroke, death, and MI rates. The anatomic patients represented a healthier and younger subset of patients, with notably low overall event rates.
由于解剖或生理因素,患者可能被认为具有颈动脉内膜切除术(CEA)的高风险,并且通常会接受经颈动脉血管重建术(TCAR)。具有生理标准的患者由于更严重的合并症,将被认为具有更高的总体手术风险。我们的目的是研究根据风险因素(解剖与生理)分层的接受 TCA 的患者中风、心肌梗死(MI)、死亡和联合终点的发生率。
对 ROADSTER(关键;颈动脉支架置入术期间使用逆行血流的安全性和有效性研究)、ROADSTER 2(食品和药物管理局指示的上市后试验;有显著颈动脉疾病的患者经颈动脉血管重建术的批准后研究)和 ROADSTER 扩展通道 TCA 试验的前瞻性收集的数据进行了分析。所有 851 例患者均被认为有 CEA 的高风险,并使用高风险解剖标准(即对侧闭塞、串联狭窄、高位颈内动脉狭窄、先前内膜切除术再狭窄、双侧颈动脉支架置入术、敌对颈部解剖结构伴先前颈部照射、颈部解剖术、颈椎活动受限)或高风险生理标准(即年龄>75 岁、多血管冠状动脉疾病、心绞痛史、充血性心力衰竭纽约心脏协会 III/IV 级、左心室射血分数<30%、近期 MI、严重慢性阻塞性肺疾病、永久性对侧颅神经损伤、慢性肾功能不全)进行分层。对于试验纳入,无症状患者需要有≥80%的颈动脉狭窄,有症状患者需要有≥50%的狭窄。主要观察指标是 30 天的中风、死亡和 MI。使用 χ 检验进行数据的统计学分析,根据需要进行。
共有 851 例高手术风险患者分为两组:仅存在解剖危险因素(n=372)或至少存在一个生理危险因素(n=479)。在 851 例患者中,解剖亚组的 74.5%为无症状患者,生理亚组的 76.6%为无症状患者。两组均相似地使用全身麻醉(67.7%解剖组 vs 68.1%生理组)。生理组有 8 例患者发生 MI(1.7%),均为无症状患者,而在解剖组中均未发生(P=0.01)。解剖队列的中风、死亡和 MI 综合发生率为 2.1%,生理队列为 4.2%(P=0.10)。对每个组进行无症状和有症状患者的分层并未产生任何其他差异。
在本前瞻性、神经学裁决试验中,由于高生理危险因素而接受 TCA 的患者的 MI 发生率高于仅使用解剖标准符合 TCA 条件的患者。这些患者的中风、死亡和 MI 综合发生率相似。解剖组的患者代表了一个更健康和更年轻的患者亚组,总体事件发生率明显较低。